Skip to main content

D 69 (Didanosine Delayed Release 200 mg)

Pill with imprint D 69 is White, Capsule-shape and has been identified as Didanosine Delayed Release 200 mg. It is supplied by Aurobindo Pharma.

Didanosine is used in the treatment of hiv infection; nonoccupational exposure and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). There is no proven risk in humans during pregnancy. Didanosine 200 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for D 69

Didanosine Delayed Release

D 69
200 mg
19.00 mm
Prescription only
Drug Class
Nucleoside reverse transcriptase inhibitors (NRTIs)
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Aurobindo Pharma
National Drug Code (NDC)
65862-0311 (Discontinued)
Inactive Ingredients
sodium starch glycolate type A potato, carboxymethylcellulose sodium, sodium lauryl sulfate, hypromellose 2910 (3 mPa.s), magnesium silicate, methacrylic acid - ethyl acrylate copolymer (1:1) type a, diethyl phthalate, silicon dioxide, gelatin, titanium dioxide, ferrosoferric oxide, shellac

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related images for "D 69"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.